Table 1: First generation stem cell-based studies in ischemic
heart disease
Study name |
Study ID, PI |
Year |
Stem Cell Type |
Cell manipulation |
Cell Number and route of administration |
Effect on Ejection Fraction (EF) |
Reinfusion of Enriched Progenitor Cells And Infarct Remodeling in Acute
Myocardial Infarction |
REPAIR-AMI Schachinger V. et al. [2] |
2006 |
BMMNCs |
Density gradient (Ficoll) centrifugation |
1.98 × 108, intracoronary injection in X-VIVO™ 10 medium and 20% autologous serum |
Positive by LV angiography |
Bone-marrow-derived cell transfer after ST-elevation
myocardial infarction |
BOOST Woller K. C. et al. [2] |
2004 |
BMMNCs |
Density gradient (Ficoll) centrifugation |
2.4 × 109, intracoronary injection (4 or five injections in heparinized saline) |
Positive by MRI |
Effects of intracoronary injection of mononuclear bone marrow cells on
left ventricular function. |
FINCELL Huikuri, H. V. et al. [3] |
2008 |
BMMNCs |
Density gradient (Ficoll) centrifugation |
3.6 × 109, intracoronary injection in unspecified medium and 50% autologous serum |
Positive by echocardiography |
Autologous Stem Cell Transplantation in Acute Myocardial Infarction |
ASTAMI Lunde K. et al. [6] |
2006 |
BMMNCs |
Density gradient (Ficoll) centrifugation |
6.8 × 107, intracoronary injection in heparin-treated plasma |
No change by CT (SPECT) |
Intracoronary infusion of mononuclear cells from bone marrow or
peripheral blood compared with standard therapy in patients after acute myocardial
infarction treated by primary PCI |
HEBE Hirsch A. et al. [5] |
2011 |
BMMNCs |
Density gradient (Lymphoprep) centrifugation |
2.96 × 108, intracoronary injection in sodium heparin and 4% Human Serum Albumin (HSA) |
No change by MRI |
SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial
Infarction |
2010 |
BMMNCs |
Density gradient (Ficoll) centrifugation |
≥ 5 × 107, intracoronary
injection In 10 ml of X-VIVO 10 with 20% of autologous serum |
No change by Cardiac magnetic resonance (CMR) |
|
Cardiac Stem Cells in patients with Ischaemic cardiomyopathy |
SCIPIO Bolli R. et al. [8] |
2011 |
c-kit-positive resident Cardiac Stem Cells |
Cell culture and Magnetic sorting (MACS) |
0.5 × 106 to 1 × 106, intracoronary
injection in PlasmaLyte A |
Positive by Echocardiography |
Intracoronary cardiosphere-derived cells for heart regeneration after
myocardial infarction |
CADUCEUS Makkar R.R. et al. [10] |
2012 |
Cardiosphere-derived cells |
Cell culture of primary explant to obtain 3D cardiospheres. |
1.3 × 107 to 2.5 × 107, intracoronary injection in
in normal saline, heparin (100 U/ml) and nitroglycerin (50 µg/ml) |
No change by cMRI. (Further advancement in ALLSTAR and RECONSTRUCT trials) |
Cardiopoietic stem Cell therapy in heart failURE |
C-CURE, Bartunek, J. et al. [11] |
2013 |
Cardiopoietic hMSCs |
Cell culture guidance and lineage
specification |
6.0 × 108 to 1.2 × 109,
NOGA guided injections of 5% HAS in lactated Ringer’s solution. |
Positive by Echocardiography. (Further advancement in CHART-1 and CHART-2 trials) |
Abbreviations: MI = Myocardial
Infarction; AMI = Acute Myocardial Infarction; BMMNCs = Bone Marrow Mononuclear
Cells; SPECT = Single-Photon Emission Computed Tomography;
LV = Left ventricular; MRI = Magnetic
Resonance Imaging; PCI = Percutaneous Coronary Intervention; hMSCs = human
Mesenchymal Stem Cells; HSA = Human Serum Albumin.